Skip to search formSkip to main contentSkip to account menu

Allotrap 1258

Known as: RDP-58, RDP58 
National Institutes of Health

Related topics

Related topics

2 relations
Delmitide

Broader (1)

allotrap

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Posters: COPD
RDP58, a D-amino acid decapeptide, inhibits TNFa, IFNg and IL-12 production in vitro and is effective in several in vivo models… 
2007
2007
Der selektive Zytokininhibitor RDP58 bei der experimentellen Kolitis der Ratte
Einfuhrung: Rational Designed Peptid (RDP) 58 ist ein topisch an der Darmschleimhaut anti-inflammatorisch wirksames Peptid. Es… 
2006
2006
RDP58 Does Not Prevent Graft-Versus-Host Disease After Dog Leukocyte Antigen–Nonidentical Canine Hematopoietic Cell Transplantation
Graft-versus-host disease (GVHD) remains a cause of substantial morbidity for patients undergoing allogeneic hematopoietic cell… 
2004
2004
RDP58, a novel immunomodulatory peptide, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalomyelitis
2004
2004
Rdp-58. Treatment of inflammatory bowel disease, TNF-α production inhibitor
Inflammatory bowel diseases (IBDs), of which Crohn's disease and ulcerative colitis are the most common, are chronic inflammatory… 
Review
2004
Review
2004
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2003
2003
RDP58, a Novel Immunomodulatory Peptide with Anti-Inflammatory Effects. A Pharmacological Study in Trinitrobenzene Sulphonic Acid Colitis and Crohn Disease
Background: Tumour necrosis factor (TNF) plays a key role in the pathogenesis of Crohn disease (CD). RDP58 is a novel anti… 
2003
2003
RDP-58: novel and effective therapy for ulcerative colitis. results of parallel, prospective, placebo-controlled trials
Review
2003
Review
2003
RDP-58 (SangStat Medical).
RDP-58, a decapeptide with inhibitory effects on tumor necrosis factor synthesis, is under development by SangStat Medical Corp… 
2003
2003
RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease.
BACKGROUND Tumour necrosis factor (TNF) plays a key role in the pathogenesis of Crohn disease (CD). RDP58 is a novel anti… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)